High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study.

Source:http://linkedlifedata.com/resource/pubmed/id/21067582

Download in:

View as

General Info

PMID
21067582